142 related articles for article (PubMed ID: 28278245)
1. Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011.
Tolppanen AM; Voutilainen A; Taipale H; Tanskanen A; Lavikainen P; Koponen M; Tiihonen J; Hartikainen S
PLoS One; 2017; 12(3):e0173450. PubMed ID: 28278245
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1729-37. PubMed ID: 25453487
[TBL] [Abstract][Full Text] [Related]
3. The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.
Saarelainen L; Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
J Alzheimers Dis; 2016; 49(3):809-18. PubMed ID: 26484930
[TBL] [Abstract][Full Text] [Related]
4. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease.
Orsel K; Taipale H; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Gardarsdottir H; Hartikainen S
Eur Neuropsychopharmacol; 2018 Nov; 28(11):1260-1269. PubMed ID: 30153953
[TBL] [Abstract][Full Text] [Related]
5. Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study.
Tolppanen AM; Taipale H; Koponen M; Lavikainen P; Tanskanen A; Tiihonen J; Hartikainen S
BMJ Open; 2016 Jul; 6(7):e012100. PubMed ID: 27412109
[TBL] [Abstract][Full Text] [Related]
6. A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland.
Moga DC; Taipale H; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Wu Q; Jicha GA; Gnjidic D
Drugs Aging; 2017 Jan; 34(1):55-65. PubMed ID: 27896799
[TBL] [Abstract][Full Text] [Related]
7. Drug use in persons with and without Alzheimer's disease aged 90 years or more.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Age Ageing; 2016 Nov; 45(6):900-904. PubMed ID: 27609205
[TBL] [Abstract][Full Text] [Related]
8. The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case-control study.
Tapiainen V; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
Acta Psychiatr Scand; 2018 Aug; 138(2):91-100. PubMed ID: 29851063
[TBL] [Abstract][Full Text] [Related]
9. Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer's disease.
Taipale H; Koponen M; Tanskanen A; Lavikainen P; Tolppanen AM; Sund R; Tiihonen J; Hartikainen S
Int Clin Psychopharmacol; 2017 May; 32(3):135-141. PubMed ID: 28072593
[TBL] [Abstract][Full Text] [Related]
10. Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in Alzheimer's disease over a three-year period: Kuopio ALSOVA study.
Törmälehto S; Martikainen J; Bell JS; Hallikainen I; Koivisto AM
Int Psychogeriatr; 2017 Oct; 29(10):1723-1733. PubMed ID: 28625207
[TBL] [Abstract][Full Text] [Related]
11. Concomitant use of benzodiazepines and opioids in community-dwelling older people with or without Alzheimer's disease-A nationwide register-based study in Finland.
Karttunen N; Taipale H; Hamina A; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S
Int J Geriatr Psychiatry; 2019 Feb; 34(2):280-288. PubMed ID: 30370943
[TBL] [Abstract][Full Text] [Related]
12. Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease.
Hamina A; Lavikainen P; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S; Taipale H
Int Psychogeriatr; 2018 Jul; 30(7):947-956. PubMed ID: 29559009
[TBL] [Abstract][Full Text] [Related]
13. Incident hip fractures among community dwelling persons with Alzheimer's disease in a Finnish nationwide register-based cohort.
Tolppanen AM; Lavikainen P; Soininen H; Hartikainen S
PLoS One; 2013; 8(3):e59124. PubMed ID: 23527106
[TBL] [Abstract][Full Text] [Related]
14. Risk of Hip Fracture in Benzodiazepine Users With and Without Alzheimer Disease.
Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Sund R; Tiihonen J; Hartikainen S; Taipale H
J Am Med Dir Assoc; 2017 Jan; 18(1):87.e15-87.e21. PubMed ID: 27847263
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease.
Sarycheva T; Taipale H; Lavikainen P; Tiihonen J; Tanskanen A; Hartikainen S; Tolppanen AM
J Alzheimers Dis; 2018; 66(1):387-395. PubMed ID: 30282366
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and characteristics of psychiatric morbidity treated in specialized health care in a nationwide cohort of people with newly diagnosed Alzheimer's disease.
Alastalo A; Tolppanen AM; Nietola M; Haapea M; Miettunen J; Hartikainen S; Jääskeläinen E
Acta Psychiatr Scand; 2022 May; 145(5):507-516. PubMed ID: 35266140
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Initiation of Potentially Inappropriate Medications in Community-Dwelling Older Adults with and without Alzheimer's Disease.
Hyttinen V; Taipale H; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S; Valtonen H
Drugs Aging; 2017 Jan; 34(1):67-77. PubMed ID: 27838819
[TBL] [Abstract][Full Text] [Related]
18. Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Int Clin Psychopharmacol; 2015 Jul; 30(4):202-8. PubMed ID: 26011780
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of pneumonia in persons with and without Alzheimer's disease: a matched cohort study.
Järvinen H; Tolppanen AM; Hartikainen S
BMC Geriatr; 2023 Apr; 23(1):227. PubMed ID: 37038120
[TBL] [Abstract][Full Text] [Related]
20. Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study.
Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Int J Geriatr Psychiatry; 2018 Apr; 33(4):583-590. PubMed ID: 29143367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
